Monograph: Cemiplimab-rwlc

Cemiplimab-rwlc

Die Inhalte stehen nur registrierten Benutzern zur Verfügung.

Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.

Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.

Full Title

Cemiplimab-rwlc

Generic Name

Cemiplimab

Chemical Name

...

INV Number

...

Classification

CAS Number

...

Introduction

Introduction

...

...

Description

...

...

Uses

Uses

...

Cutaneous Squamous Cell Carcinoma

...

...

Dosage and Administration

Dosage and Administration

...

General

...

Restricted Distribution

...

Administration

...

Dosage

...

Cutaneous Squamous Cell Carcinoma

...

Therapy Interruption for Toxicity

...

Immune-mediated Pneumonitis

...

Immune-mediated GI Effects

...

Immune-mediated Hepatic Effects

...

Immune-mediated Endocrine Effects

...

Other Immune-mediated Adverse Effects

...

Infusion-related Reactions

...

Special Populations

...

...

Cautions

Cautions

...

Contraindications

...

Warnings/Precautions

...

Immune-mediated Pneumonitis

...

Immune-mediated GI Effects

...

Immune-mediated Hepatic Effects

...

Immune-mediated Endocrine Effects

...

Adrenal Insufficiency

...

Hypophysitis

...

Thyroid Dysfunction

...

Diabetes Mellitus

...

Immune-mediated Renal Effects

...

Immune-mediated Dermatologic Effects

...

Other Immune-mediated Effects

...

Infusion-related Effects

...

Fetal/Neonatal Morbidity and Mortality

...

Immunogenicity

...

Specific Populations

...

Pregnancy

...

Lactation

...

Pediatric Use

...

Geriatric Use

...

Hepatic Impairment

...

Renal Impairment

...

Common Adverse Effects

...

...

Drug Interactions

Drug Interactions

...

...

Advice to Patients

Advice to Patients

...

...

Preparations

Preparations

...

Cemiplimab-rwlc

...

...

Common general statement Elements

Additional Information

...

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2019, Selected Revisions August 26, 2019. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

Quelle

AHFS Drug Information